Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-12-03 Purchase |
2020-12-04 9:39 pm |
Kinnate Biopharma Inc. | KNTE | Tananbaum James B. Director 10% Owner |
1,000,000 | $20 | $20,000,000 | 125,000 (Indirect) |
View |
| 2020-12-02 Purchase |
2020-12-04 6:11 pm |
Kinnate Biopharma Inc. | KNTE | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director 10% Owner |
750,000 | $20 | $15,000,000 | 450,000 (Indirect) |
View |
| 2020-12-02 Purchase |
2020-12-04 5:13 pm |
Kinnate Biopharma Inc. | KNTE | GORDON CARL L Director 10% Owner |
750,000 | $20 | $15,000,000 | 450,000 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-06-07 Option Award |
2021-06-08 8:32 pm |
N/A 2031-06-07 |
Kinnate Biopharma Inc. | KNTE | Krishnamohan Neha Chief Financial Officer |
270,000 | $0 | 270,000 (Direct) |
View |
| 2021-02-12 Option Award |
2021-02-16 6:07 pm |
N/A 2031-02-12 |
Kinnate Biopharma Inc. | KNTE | Williams Richard Thomas Chief Medical Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-02-12 Option Award |
2021-02-16 6:03 pm |
N/A 2031-02-12 |
Kinnate Biopharma Inc. | KNTE | Murphy Eric Anthony Chief Scientific Officer |
60,000 | $0 | 60,000 (Direct) |
View |
| 2021-02-12 Option Award |
2021-02-16 6:00 pm |
N/A 2031-02-12 |
Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO General Counsel Treasurer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-02-12 Option Award |
2021-02-16 5:54 pm |
N/A 2031-02-12 |
Kinnate Biopharma Inc. | KNTE | Farzan Nima Chief Executive Officer |
275,000 | $0 | 275,000 (Direct) |
View |
| 2020-12-07 Conversion |
2020-12-09 4:24 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC Director 10% Owner |
3,240,882 | $0 | 534,599 (Indirect) |
View |
| 2020-12-07 Conversion |
2020-12-09 4:18 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | GORDON CARL L Director 10% Owner |
3,240,882 | $0 | 534,599 (Indirect) |
View |
| 2020-12-07 Conversion |
2020-12-09 4:12 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | Tananbaum James B. Director 10% Owner |
19,675,448 | $0 | 291,667 (Indirect) |
View |
| 2020-12-07 Conversion |
2020-12-09 1:35 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | Foresite Capital Management IV LLC Foresite Capital Fund IV L.P. Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Management V LLC Foresite Capital Opportunity Fund V L.P. 10% Owner |
19,675,448 | $0 | 291,667 (Indirect) |
View |
| 2020-12-03 Option Award |
2020-12-04 8:57 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | Foresite Capital Management IV LLC Foresite Capital Fund IV L.P. Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Management V LLC Foresite Capital Opportunity Fund V L.P. 10% Owner |
1,000,000 | $20 | 125,000 (Indirect) |
View |
| 2020-12-02 Option Award |
2020-12-04 6:32 pm |
N/A 2030-12-02 |
Kinnate Biopharma Inc. | KNTE | Tananbaum James B. Director 10% Owner |
40,501 | $0 | 40,501 (Direct) |
View |
| 2020-12-02 Option Award |
2020-12-04 6:30 pm |
N/A 2030-12-02 |
Kinnate Biopharma Inc. | KNTE | Rome Michael E Director |
40,501 | $0 | 40,501 (Direct) |
View |
| 2020-12-02 Option Award |
2020-12-04 06:03 am |
N/A 2030-12-02 |
Kinnate Biopharma Inc. | KNTE | GORDON CARL L Director 10% Owner |
40,501 | $0 | 40,501 (Direct) |
View |
Ownership |
2020-12-03 06:03 am |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | Foresite Capital Management IV LLC Foresite Capital Fund IV L.P. Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Management V LLC Foresite Capital Opportunity Fund V L.P. 10% Owner |
0 | $0 | 9,838,311 (Indirect) |
View |
Ownership |
2020-12-02 9:14 pm |
2020-03-23 2030-03-23 |
Kinnate Biopharma Inc. | KNTE | Farzan Nima President and CEO |
0 | $0 | 1,719,055 (Direct) |
View |
Ownership |
2020-12-02 9:13 pm |
N/A 2030-08-18 |
Kinnate Biopharma Inc. | KNTE | MITCHELL DEAN J Director |
0 | $0 | 121,503 (Direct) |
View |
Ownership |
2020-12-02 9:12 pm |
2020-04-02 2030-04-02 |
Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO General Counsel Treasurer |
0 | $0 | 506,011 (Direct) |
View |
Ownership |
2020-12-02 9:11 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | Flaherty Keith T. Director |
0 | $0 | 165,944 (Direct) |
View |
Ownership |
2020-12-02 9:10 pm |
N/A 2030-10-23 |
Kinnate Biopharma Inc. | KNTE | Epperly Melissa B Director |
0 | $0 | 60,751 (Direct) |
View |
Ownership |
2020-12-02 9:10 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | Kaldor Stephen W Director |
0 | $0 | 1,941,006 (Direct) |
View |
Ownership |
2020-12-02 9:09 pm |
N/A 2030-06-22 |
Kinnate Biopharma Inc. | KNTE | Williams Richard Thomas Chief Medical Officer |
0 | $0 | 437,412 (Direct) |
View |
Ownership |
2020-12-02 9:08 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | Murphy Eric Anthony Chief Scientific Officer |
0 | $0 | 2,052,969 (Direct) |
View |
Ownership |
2020-12-02 9:07 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | GORDON CARL L Director 10% Owner |
0 | $0 | 3,097,929 (Indirect) |
View |
Ownership |
2020-12-02 9:07 pm |
N/A 2030-08-22 |
Kinnate Biopharma Inc. | KNTE | Smaldone Alsup Laurie Director |
0 | $0 | 60,751 (Direct) |
View |
Ownership |
2020-12-02 9:07 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner |
0 | $0 | 3,097,929 (Indirect) |
View |
Ownership |
2020-12-02 9:06 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | Tananbaum James B. Director 10% Owner |
0 | $0 | 9,838,311 (Indirect) |
View |